{
    "id": 47,
    "premise": "none",
    "hypothesis": "PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA.",
    "label": "entailment",
    "explanation": "Inhibition of PARP results in collapsed replication forks and DSB.\nLoss of BRCA2 drives cancer development via genomic instability.\nProposal: Trapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity.",
    "results": {
        "semantic validity": false,
        "premise": null,
        "hypothesis": "PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA.",
        "history explanation": [
            "0 iteration: Inhibition of PARP results in collapsed replication forks and DSB.\nLoss of BRCA2 drives cancer development via genomic instability.\nProposal: Trapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity.",
            "1 iteration: Inhibition of PARP results in collapsed replication forks and DSB, and prevents SS break repair.\nLoss of BRCA2 drives cancer development via genomic instability, which involves defective HRR.\nTrapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity, indicating reliance on error-prone NHEJ for DNA repair.",
            "2 iteration: Inhibition of PARP results in collapsed replication forks and DSB, and prevents SS break repair.\nLoss of BRCA2 drives cancer development via genomic instability, which involves defective HRR.\nTrapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity, indicating reliance on error-prone NHEJ for DNA repair.",
            "3 iteration: Inhibition of PARP results in collapsed replication forks and DSB, and prevents SS break repair.\nLoss of BRCA2 drives cancer development via genomic instability, which involves defective HRR.\nTrapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity, indicating reliance on error-prone NHEJ for DNA repair.",
            "4 iteration: Inhibition of PARP results in collapsed replication forks and DSB, and prevents SS break repair.\nLoss of BRCA2 drives cancer development via genomic instability, which involves defective HRR.\nTrapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity, indicating reliance on error-prone NHEJ for DNA repair.",
            "5 iteration: Inhibition of PARP results in collapsed replication forks and DSB, and prevents SS break repair.\nLoss of BRCA2 drives cancer development via genomic instability, which involves defective HRR.\nTrapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity, indicating reliance on error-prone NHEJ for DNA repair.",
            "6 iteration: Inhibition of PARP directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks.\nLoss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair.\nTrapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair.",
            "7 iteration: PARP inhibitors function by inhibiting PARP, which directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks.\nLoss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair.\nTrapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair.",
            "8 iteration: PARP inhibitors function by inhibiting PARP, which directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks.\nLoss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair.\nTrapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair.\nThe inhibition of PARP by PARP inhibitors directly leads to the occurrence of double-strand breaks.",
            "9 iteration: PARP inhibitors function by inhibiting PARP, which directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks and reliance on error-prone non-homologous end joining for DNA repair.\nLoss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair.\nTrapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair.\nThe inhibition of PARP by PARP inhibitors directly leads to the occurrence of double-strand breaks and prevents single-strand break repair, which contributes to defective homologous recombination repair.",
            "10 iteration: PARP inhibitors function by inhibiting PARP, which directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks and reliance on error-prone non-homologous end joining for DNA repair.\nLoss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair.\nTrapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair.\nThe inhibition of PARP by PARP inhibitors directly leads to the occurrence of double-strand breaks and prevents single-strand break repair, which contributes to defective homologous recombination repair.\nThe inhibition of PARP by PARP inhibitors directly causes double-strand breaks, which leads to reliance on error-prone non-homologous end joining for DNA repair."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: False",
            "3 iteration: False",
            "4 iteration: False",
            "5 iteration: False",
            "6 iteration: False",
            "7 iteration: False",
            "8 iteration: False",
            "9 iteration: False",
            "10 iteration: False"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': 'then have \"\u2203e1. Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y\" sledgehammer', 'solving time': 103.89405751228333, 'proof tactics': [], 'code': 'theory clinical_47_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Inhibition :: \"entity \u21d2 bool\"\\n  PARP :: \"entity \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"event \u21d2 entity \u21d2 bool\"\\n  Forks :: \"entity\"\\n  DSB :: \"entity\"\\n  Loss :: \"entity \u21d2 bool\"\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  CancerDevelopment :: \"entity \u21d2 bool\"\\n  Drive :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  GenomicInstability :: \"entity\"\\n  Trapping :: \"entity \u21d2 bool\"\\n  PARP1 :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  Increase :: \"event \u21d2 bool\"\\n  NHEJ :: \"entity\"\\n  Toxicity :: \"entity\"\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  On :: \"event \u21d2 entity \u21d2 bool\"\\n  HRR :: \"entity\"\\n  Repair :: \"event \u21d2 entity \u21d2 bool\"\\n  DNA :: \"entity\"\\n\\n(* Explanation 1: Inhibition of PARP results in collapsed replication forks and DSB. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y e. Inhibition x \u2227 PARP y \u2227 Result e \u2227 Agent e x \u2227 In e Forks \u2227 In e DSB\"\\n\\n(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. Loss x \u2227 BRCA2 y \u2227 CancerDevelopment z \u2227 Drive e \u2227 Agent e x \u2227 Patient e z \u2227 Via e GenomicInstability\"\\n\\n(* Explanation 3: Proposal: Trapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2. Trapping x \u2227 PARP1 y \u2227 DSBs z \u2227 Increase e1 \u2227 Agent e1 x \u2227 Patient e1 NHEJ \u2227 Increase e2 \u2227 Agent e2 x \u2227 Patient e2 Toxicity\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z\"\\n  (* Hypothesis: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)\\n  shows \"\u2203x y z e1 e2 e3. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 On e3 HRR \u2227 On e3 NHEJ \u2227 Repair e3 DNA\"\\nproof -\\n  (* From the known information, we have PARPInhibitors x, DSBs y, and SSBreakRepair z. *)\\n  from asm have \"PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z\" <ATP>\\n  \\n  (* Explanation 1 states that inhibition of PARP results in DSB. \\n     We have a derived implication: Implies(A, C), which means inhibition of PARP implies DSB. \\n     Since we have DSBs y, we can infer that there is an inhibition of PARP. *)\\n  then have \"\u2203e1. Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y\" <ATP>\\n  \\n  (* Explanation 3 suggests that trapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity.\\n     We have a logical relation: Implies(G, H), which means trapping of PARP1 at sites of DSBs implies increased NHEJ.\\n     Since we have DSBs y, we can infer that there is trapping of PARP1, leading to increased NHEJ. *)\\n  then have \"\u2203e3. Rely e3 \u2227 Agent e3 x \u2227 On e3 NHEJ\" <ATP>\\n  \\n  (* The hypothesis also involves preventing SS break repair and relying on defective HRR.\\n     Since we have SSBreakRepair z, we can infer that there is prevention of SS break repair. *)\\n  then have \"\u2203e2. Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z\" <ATP>\\n  \\n  (* Finally, we need to show that the process relies on defective HRR to repair DNA. \\n     This is part of the hypothesis and can be inferred from the reliance on NHEJ and the context of the problem. *)\\n  then have \"\u2203e3. Rely e3 \u2227 Agent e3 x \u2227 On e3 HRR \u2227 Repair e3 DNA\" <ATP>\\n  \\n  (* Combining all the inferred parts, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: inhibition of PARP (from Explanatory Sentence 1)\\nB: collapsed replication forks (from Explanatory Sentence 1)\\nC: DSB (double-strand breaks) (from Explanatory Sentence 1)\\nD: loss of BRCA2 (from Explanatory Sentence 2)\\nE: cancer development (from Explanatory Sentence 2)\\nF: genomic instability (from Explanatory Sentence 2)\\nG: trapping of PARP1 at sites of DSBs (from Explanatory Sentence 3)\\nH: increased NHEJ (non-homologous end joining) (from Explanatory Sentence 3)\\nI: increased toxicity (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, And(B, C))\\nImplies(inhibition of PARP, B & C)\\n--------\\nImplies(D, And(E, F))\\nImplies(loss of BRCA2, E & F)\\n--------\\nImplies(G, And(H, I))\\nImplies(trapping of PARP1 at sites of DSBs, H & I)\\n--------\\n\\nDerived Implications:\\nImplies(Not(F), Not(D))\\nImplies(Not(genomic instability), Not(loss of BRCA2))\\n--------\\nImplies(Not(H), Not(G))\\nImplies(Not(increased NHEJ), Not(trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(Not(I), Not(G))\\nImplies(Not(increased toxicity), Not(trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(A, C)\\nImplies(inhibition of PARP, DSB)\\n--------\\nImplies(D, E)\\nImplies(loss of BRCA2, cancer development)\\n--------\\nImplies(D, F)\\nImplies(loss of BRCA2, genomic instability)\\n--------\\nImplies(Not(E), Not(D))\\nImplies(Not(cancer development), Not(loss of BRCA2))\\n--------\\nImplies(G, I)\\nImplies(trapping of PARP1 at sites of DSBs, increased toxicity)\\n--------\\nImplies(A, B)\\nImplies(inhibition of PARP, collapsed replication forks)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(collapsed replication forks), Not(inhibition of PARP))\\n--------\\nImplies(G, H)\\nImplies(trapping of PARP1 at sites of DSBs, increased NHEJ)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(DSB), Not(inhibition of PARP))\\n--------\\n'}",
            "1 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 6.8664538860321045, 'proof tactics': ['Type unification failed: Clash of types \"_ \\\\<Rightarrow> _\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  On e3 :: entity \\\\<Rightarrow> bool\\nOperand:   HRR :: entity \\\\<Rightarrow> bool\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_47_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  InhibitionPARP :: \"entity \u21d2 bool\"\\n  Forks :: \"entity \u21d2 bool\"\\n  DSB :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  LossBRCA2 :: \"entity \u21d2 bool\"\\n  CancerDevelopment :: \"entity \u21d2 bool\"\\n  GenomicInstability :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Drive :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Involve :: \"event \u21d2 bool\"\\n  TrappingPARP1 :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  Toxicity :: \"entity \u21d2 bool\"\\n  DNARepair :: \"entity \u21d2 bool\"\\n  Increase :: \"event \u21d2 bool\"\\n  Indicate :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  On :: \"event \u21d2 entity \u21d2 bool\"\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Inhibition of PARP results in collapsed replication forks and DSB, and prevents SS break repair. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z w e1 e2. InhibitionPARP x \u2227 Forks y \u2227 DSB z \u2227 SSBreakRepair w \u27f6 (Result e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Patient e1 z \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 w)\"\\n\\n(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective HRR. *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z w e1 e2. LossBRCA2 x \u2227 CancerDevelopment y \u2227 GenomicInstability z \u2227 HRR w \u27f6 (Drive e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Via e1 z \u2227 Involve e2 \u2227 Agent e2 z \u2227 Patient e2 w)\"\\n\\n(* Explanation 3: Trapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity, indicating reliance on error-prone NHEJ for DNA repair. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z w v e1 e2 e3. TrappingPARP1 x \u2227 DSBs y \u2227 NHEJ z \u2227 Toxicity w \u2227 DNARepair v \u27f6 (Increase e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Increase e2 \u2227 Agent e2 x \u2227 Patient e2 w \u2227 Indicate e3 \u2227 Agent e3 x \u2227 Patient e3 v \u2227 Rely e3 \u2227 On e3 z)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z\"\\n  (* Hypothesis: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)\\n  shows \"\u2203x y z e1 e2 e3. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 On e3 HRR \u2227 On e3 NHEJ\"\\nproof -\\n  (* From the known information, we have PARPInhibitors x, DSBs y, and SSBreakRepair z. *)\\n  from asm have \"PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z\" <ATP>\\n  \\n  (* Explanation 1 states that Inhibition of PARP results in DSB and prevents SS break repair. *)\\n  (* We can use the logical relation Implies(A, C) and Implies(A, D) to infer that if PARP is inhibited, it causes DSBs and prevents SS break repair. *)\\n  (* Since we have DSBs y and SSBreakRepair z, we can infer that PARP inhibitors cause replication-associated DSBs by preventing SS break repair. *)\\n  then have \"Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z\" <ATP>\\n  \\n  (* Explanation 2 and the logical relation Implies(E, H) indicate that loss of BRCA2 involves defective HRR. *)\\n  (* Although we don\\'t have direct information about BRCA2, we can assume reliance on defective HRR for DNA repair. *)\\n  (* Explanation 3 and the logical relation Implies(I, L) indicate reliance on error-prone NHEJ for DNA repair. *)\\n  (* We can infer that PARP inhibitors rely on defective HRR and error-prone NHEJ to repair DNA. *)\\n  then have \"Rely e3 \u2227 Agent e3 x \u2227 On e3 HRR \u2227 On e3 NHEJ\" <ATP>\\n  \\n  (* Combining all the inferred information, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Inhibition of PARP (from Explanatory Sentence 1)\\nB: Collapsed replication forks (from Explanatory Sentence 1)\\nC: DSB (double-strand breaks) (from Explanatory Sentence 1)\\nD: Prevention of SS (single-strand) break repair (from Explanatory Sentence 1)\\nE: Loss of BRCA2 (from Explanatory Sentence 2)\\nF: Cancer development (from Explanatory Sentence 2)\\nG: Genomic instability (from Explanatory Sentence 2)\\nH: Defective HRR (homologous recombination repair) (from Explanatory Sentence 2)\\nI: Trapping of PARP1 at sites of DSBs (from Explanatory Sentence 3)\\nJ: Increased NHEJ (non-homologous end joining) (from Explanatory Sentence 3)\\nK: Increased toxicity (from Explanatory Sentence 3)\\nL: Reliance on error-prone NHEJ for DNA repair (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, And(B, C, D))\\nImplies(Inhibition of PARP, B & C & D)\\n--------\\nImplies(E, And(F, G, H))\\nImplies(Loss of BRCA2, F & G & H)\\n--------\\nImplies(I, And(J, K, L))\\nImplies(Trapping of PARP1 at sites of DSBs, J & K & L)\\n--------\\n\\nDerived Implications:\\nImplies(Not(D), Not(A))\\nImplies(Not(Prevention of SS  break repair), Not(Inhibition of PARP))\\n--------\\nImplies(Not(G), Not(E))\\nImplies(Not(Genomic instability), Not(Loss of BRCA2))\\n--------\\nImplies(I, K)\\nImplies(Trapping of PARP1 at sites of DSBs, Increased toxicity)\\n--------\\nImplies(A, C)\\nImplies(Inhibition of PARP, DSB)\\n--------\\nImplies(Not(F), Not(E))\\nImplies(Not(Cancer development), Not(Loss of BRCA2))\\n--------\\nImplies(E, H)\\nImplies(Loss of BRCA2, Defective HRR)\\n--------\\nImplies(Not(K), Not(I))\\nImplies(Not(Increased toxicity), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(E, G)\\nImplies(Loss of BRCA2, Genomic instability)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(DSB), Not(Inhibition of PARP))\\n--------\\nImplies(I, J)\\nImplies(Trapping of PARP1 at sites of DSBs, Increased NHEJ)\\n--------\\nImplies(A, B)\\nImplies(Inhibition of PARP, Collapsed replication forks)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(Collapsed replication forks), Not(Inhibition of PARP))\\n--------\\nImplies(A, D)\\nImplies(Inhibition of PARP, Prevention of SS  break repair)\\n--------\\nImplies(Not(H), Not(E))\\nImplies(Not(Defective HRR), Not(Loss of BRCA2))\\n--------\\nImplies(Not(J), Not(I))\\nImplies(Not(Increased NHEJ), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(E, F)\\nImplies(Loss of BRCA2, Cancer development)\\n--------\\nImplies(Not(L), Not(I))\\nImplies(Not(Reliance on error-prone NHEJ for DNA repair), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(I, L)\\nImplies(Trapping of PARP1 at sites of DSBs, Reliance on error-prone NHEJ for DNA repair)\\n--------\\n'}",
            "2 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 9.23473310470581, 'proof tactics': ['Type unification failed: Clash of types \"_ \\\\<Rightarrow> _\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  On e3 :: entity \\\\<Rightarrow> bool\\nOperand:   HRR :: entity \\\\<Rightarrow> bool\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_47_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  InhibitionOfPARP :: \"entity \u21d2 bool\"\\n  Forks :: \"entity \u21d2 bool\"\\n  DSB :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  LossOfBRCA2 :: \"entity \u21d2 bool\"\\n  CancerDevelopment :: \"entity \u21d2 bool\"\\n  GenomicInstability :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Drive :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Involve :: \"event \u21d2 bool\"\\n  TrappingOfPARP1 :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  Toxicity :: \"entity \u21d2 bool\"\\n  DNARepair :: \"entity \u21d2 bool\"\\n  Increase :: \"event \u21d2 bool\"\\n  Indicate :: \"event \u21d2 bool\"\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  On :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Inhibition of PARP results in collapsed replication forks and DSB, and prevents SS break repair. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z w e1 e2. InhibitionOfPARP x \u2227 Forks y \u2227 DSB z \u2227 SSBreakRepair w \u27f6 (Result e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Patient e1 z \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 w)\"\\n\\n(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective HRR. *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z w e1 e2. LossOfBRCA2 x \u2227 CancerDevelopment y \u2227 GenomicInstability z \u2227 HRR w \u27f6 (Drive e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Via e1 z \u2227 Involve e2 \u2227 Agent e2 z \u2227 Patient e2 w)\"\\n\\n(* Explanation 3: Trapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity, indicating reliance on error-prone NHEJ for DNA repair. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z w v e1 e2 e3. TrappingOfPARP1 x \u2227 DSBs y \u2227 NHEJ z \u2227 Toxicity w \u2227 DNARepair v \u27f6 (Increase e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Increase e2 \u2227 Agent e2 x \u2227 Patient e2 w \u2227 Indicate e3 \u2227 Agent e3 x \u2227 Patient e3 v)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z\"\\n  (* Hypothesis: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)\\n  shows \"\u2203x y z e1 e2 e3. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u27f6 (Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 On e3 HRR \u2227 On e3 NHEJ)\"\\nproof -\\n  (* From the premise, we have known information about PARP inhibitors, DSBs, and SS break repair. *)\\n  from asm have \"PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z\" <ATP>\\n  (* Explanation 1 states that inhibition of PARP results in DSB and prevents SS break repair. *)\\n  (* We can use the logical relation Implies(A, C) and Implies(A, D) to infer that PARP inhibitors cause DSBs and prevent SS break repair. *)\\n  have \"Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z\" <ATP>\\n  (* Explanation 2 and 3 are not directly relevant to the hypothesis, but we need to show reliance on defective HRR and error-prone NHEJ. *)\\n  (* Explanation 3 indicates reliance on error-prone NHEJ for DNA repair. *)\\n  (* We can use the logical relation Implies(I, L) to infer reliance on error-prone NHEJ. *)\\n  have \"Rely e3 \u2227 Agent e3 x \u2227 On e3 HRR \u2227 On e3 NHEJ\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Inhibition of PARP (from Explanatory Sentence 1)\\nB: Collapsed replication forks (from Explanatory Sentence 1)\\nC: DSB (double-strand breaks) (from Explanatory Sentence 1)\\nD: Prevention of SS (single-strand) break repair (from Explanatory Sentence 1)\\nE: Loss of BRCA2 (from Explanatory Sentence 2)\\nF: Cancer development (from Explanatory Sentence 2)\\nG: Genomic instability (from Explanatory Sentence 2)\\nH: Defective HRR (homologous recombination repair) (from Explanatory Sentence 2)\\nI: Trapping of PARP1 at sites of DSBs (from Explanatory Sentence 3)\\nJ: Increase in NHEJ (non-homologous end joining) (from Explanatory Sentence 3)\\nK: Increase in toxicity (from Explanatory Sentence 3)\\nL: Reliance on error-prone NHEJ for DNA repair (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, And(B, C, D))\\nImplies(Inhibition of PARP, B & C & D)\\n--------\\nImplies(E, And(F, G, H))\\nImplies(Loss of BRCA2, F & G & H)\\n--------\\nImplies(I, And(J, K, L))\\nImplies(Trapping of PARP1 at sites of DSBs, J & K & L)\\n--------\\n\\nDerived Implications:\\nImplies(Not(D), Not(A))\\nImplies(Not(Prevention of SS  break repair), Not(Inhibition of PARP))\\n--------\\nImplies(Not(G), Not(E))\\nImplies(Not(Genomic instability), Not(Loss of BRCA2))\\n--------\\nImplies(I, K)\\nImplies(Trapping of PARP1 at sites of DSBs, Increase in toxicity)\\n--------\\nImplies(A, C)\\nImplies(Inhibition of PARP, DSB)\\n--------\\nImplies(Not(F), Not(E))\\nImplies(Not(Cancer development), Not(Loss of BRCA2))\\n--------\\nImplies(E, H)\\nImplies(Loss of BRCA2, Defective HRR)\\n--------\\nImplies(Not(K), Not(I))\\nImplies(Not(Increase in toxicity), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(E, G)\\nImplies(Loss of BRCA2, Genomic instability)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(DSB), Not(Inhibition of PARP))\\n--------\\nImplies(I, J)\\nImplies(Trapping of PARP1 at sites of DSBs, Increase in NHEJ)\\n--------\\nImplies(A, B)\\nImplies(Inhibition of PARP, Collapsed replication forks)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(Collapsed replication forks), Not(Inhibition of PARP))\\n--------\\nImplies(A, D)\\nImplies(Inhibition of PARP, Prevention of SS  break repair)\\n--------\\nImplies(Not(H), Not(E))\\nImplies(Not(Defective HRR), Not(Loss of BRCA2))\\n--------\\nImplies(Not(J), Not(I))\\nImplies(Not(Increase in NHEJ), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(E, F)\\nImplies(Loss of BRCA2, Cancer development)\\n--------\\nImplies(Not(L), Not(I))\\nImplies(Not(Reliance on error-prone NHEJ for DNA repair), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(I, L)\\nImplies(Trapping of PARP1 at sites of DSBs, Reliance on error-prone NHEJ for DNA repair)\\n--------\\n'}",
            "3 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 15.269396781921387, 'proof tactics': ['Type unification failed: Clash of types \"_ \\\\<Rightarrow> _\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  On e3 :: entity \\\\<Rightarrow> bool\\nOperand:   HRR :: entity \\\\<Rightarrow> bool\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_47_3\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  InhibitionOfPARP :: \"entity \u21d2 bool\"\\n  Forks :: \"entity \u21d2 bool\"\\n  DSB :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  LossOfBRCA2 :: \"entity \u21d2 bool\"\\n  CancerDevelopment :: \"entity \u21d2 bool\"\\n  GenomicInstability :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Drive :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Involve :: \"event \u21d2 bool\"\\n  TrappingOfPARP1 :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  Toxicity :: \"entity \u21d2 bool\"\\n  DNARepair :: \"entity \u21d2 bool\"\\n  Increase :: \"event \u21d2 bool\"\\n  Indicate :: \"event \u21d2 bool\"\\n  Reliance :: \"event \u21d2 entity \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  On :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Inhibition of PARP results in collapsed replication forks and DSB, and prevents SS break repair. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z w e1 e2. InhibitionOfPARP x \u2227 Forks y \u2227 DSB z \u2227 SSBreakRepair w \u27f6 (Result e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Patient e1 z \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 w)\"\\n\\n(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective HRR. *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z w e1 e2. LossOfBRCA2 x \u2227 CancerDevelopment y \u2227 GenomicInstability z \u2227 HRR w \u27f6 (Drive e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Via e1 z \u2227 Involve e2 \u2227 Agent e2 z \u2227 Patient e2 w)\"\\n\\n(* Explanation 3: Trapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity, indicating reliance on error-prone NHEJ for DNA repair. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z w v e1 e2 e3. TrappingOfPARP1 x \u2227 DSBs y \u2227 NHEJ z \u2227 Toxicity w \u2227 DNARepair v \u27f6 (Increase e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Increase e2 \u2227 Agent e2 x \u2227 Patient e2 w \u2227 Indicate e3 \u2227 Agent e3 x \u2227 Reliance e3 z \u2227 For e3 v)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z\"\\n  (* Hypothesis: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)\\n  shows \"\u2203x y z e1 e2 e3. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u27f6 (Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 On e3 HRR \u2227 On e3 NHEJ)\"\\nproof -\\n  (* From the known information, we have PARPInhibitors x, DSBs y, and SSBreakRepair z. *)\\n  from asm have \"PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z\" <ATP>\\n  \\n  (* Explanation 1 states that Inhibition of PARP results in DSB and prevents SS break repair. *)\\n  (* We can use the logical relation Implies(A, C) and Implies(A, D) to infer DSB and prevention of SS break repair. *)\\n  have \"InhibitionOfPARP x \u27f6 (DSB y \u2227 SSBreakRepair z)\" <ATP>\\n  \\n  (* Explanation 3 states that Trapping of PARP1 at sites of DSBs indicates reliance on error-prone NHEJ for DNA repair. *)\\n  (* We can use the logical relation Implies(I, L) to infer reliance on error-prone NHEJ. *)\\n  have \"TrappingOfPARP1 x \u27f6 Reliance e3 NHEJ\" <ATP>\\n  \\n  (* We need to show that PARP inhibitors cause replication-associated DSBs by preventing SS break repair, relying on defective HRR and error-prone NHEJ. *)\\n  (* We can combine these inferences to construct the hypothesis. *)\\n  then have \"Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 On e3 HRR \u2227 On e3 NHEJ\" <ATP>\\n  \\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Inhibition of PARP (from Explanatory Sentence 1)\\nB: Collapsed replication forks (from Explanatory Sentence 1)\\nC: DSB (double-strand breaks) (from Explanatory Sentence 1)\\nD: Prevention of SS (single-strand) break repair (from Explanatory Sentence 1)\\nE: Loss of BRCA2 (from Explanatory Sentence 2)\\nF: Cancer development (from Explanatory Sentence 2)\\nG: Genomic instability (from Explanatory Sentence 2)\\nH: Defective HRR (homologous recombination repair) (from Explanatory Sentence 2)\\nI: Trapping of PARP1 at sites of DSBs (from Explanatory Sentence 3)\\nJ: Increased NHEJ (non-homologous end joining) (from Explanatory Sentence 3)\\nK: Increased toxicity (from Explanatory Sentence 3)\\nL: Reliance on error-prone NHEJ for DNA repair (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, And(B, C, D))\\nImplies(Inhibition of PARP, B & C & D)\\n--------\\nImplies(E, And(F, G, H))\\nImplies(Loss of BRCA2, F & G & H)\\n--------\\nImplies(I, And(J, K, L))\\nImplies(Trapping of PARP1 at sites of DSBs, J & K & L)\\n--------\\n\\nDerived Implications:\\nImplies(Not(D), Not(A))\\nImplies(Not(Prevention of SS  break repair), Not(Inhibition of PARP))\\n--------\\nImplies(Not(G), Not(E))\\nImplies(Not(Genomic instability), Not(Loss of BRCA2))\\n--------\\nImplies(I, K)\\nImplies(Trapping of PARP1 at sites of DSBs, Increased toxicity)\\n--------\\nImplies(A, C)\\nImplies(Inhibition of PARP, DSB)\\n--------\\nImplies(Not(F), Not(E))\\nImplies(Not(Cancer development), Not(Loss of BRCA2))\\n--------\\nImplies(E, H)\\nImplies(Loss of BRCA2, Defective HRR)\\n--------\\nImplies(Not(K), Not(I))\\nImplies(Not(Increased toxicity), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(E, G)\\nImplies(Loss of BRCA2, Genomic instability)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(DSB), Not(Inhibition of PARP))\\n--------\\nImplies(I, J)\\nImplies(Trapping of PARP1 at sites of DSBs, Increased NHEJ)\\n--------\\nImplies(A, B)\\nImplies(Inhibition of PARP, Collapsed replication forks)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(Collapsed replication forks), Not(Inhibition of PARP))\\n--------\\nImplies(A, D)\\nImplies(Inhibition of PARP, Prevention of SS  break repair)\\n--------\\nImplies(Not(H), Not(E))\\nImplies(Not(Defective HRR), Not(Loss of BRCA2))\\n--------\\nImplies(Not(J), Not(I))\\nImplies(Not(Increased NHEJ), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(E, F)\\nImplies(Loss of BRCA2, Cancer development)\\n--------\\nImplies(Not(L), Not(I))\\nImplies(Not(Reliance on error-prone NHEJ for DNA repair), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(I, L)\\nImplies(Trapping of PARP1 at sites of DSBs, Reliance on error-prone NHEJ for DNA repair)\\n--------\\n'}",
            "4 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 1.4330670833587646, 'proof tactics': ['Type unification failed: Clash of types \"_ \\\\<Rightarrow> _\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  On e3 :: entity \\\\<Rightarrow> bool\\nOperand:   HRR :: entity \\\\<Rightarrow> bool\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_47_4\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  InhibitionOfPARP :: \"entity \u21d2 bool\"\\n  Forks :: \"entity \u21d2 bool\"\\n  DSB :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  LossOfBRCA2 :: \"entity \u21d2 bool\"\\n  CancerDevelopment :: \"entity \u21d2 bool\"\\n  GenomicInstability :: \"entity \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  Drive :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Involve :: \"event \u21d2 bool\"\\n  TrappingOfPARP1 :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  Toxicity :: \"entity \u21d2 bool\"\\n  DNARepair :: \"entity \u21d2 bool\"\\n  Increase :: \"event \u21d2 bool\"\\n  Indicate :: \"event \u21d2 bool\"\\n  Reliance :: \"event \u21d2 entity \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  On :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Inhibition of PARP results in collapsed replication forks and DSB, and prevents SS break repair. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z w e1 e2. InhibitionOfPARP x \u2227 Forks y \u2227 DSB z \u2227 SSBreakRepair w \u27f6 (Result e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Patient e1 z \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 w)\"\\n\\n(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective HRR. *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z w e1 e2. LossOfBRCA2 x \u2227 CancerDevelopment y \u2227 GenomicInstability z \u2227 HRR w \u27f6 (Drive e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Via e1 z \u2227 Involve e2 \u2227 Agent e2 z \u2227 Patient e2 w)\"\\n\\n(* Explanation 3: Trapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity, indicating reliance on error-prone NHEJ for DNA repair. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z w v e1 e2 e3. TrappingOfPARP1 x \u2227 DSBs y \u2227 NHEJ z \u2227 Toxicity w \u2227 DNARepair v \u27f6 (Increase e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Increase e2 \u2227 Agent e2 x \u2227 Patient e2 w \u2227 Indicate e3 \u2227 Agent e3 x \u2227 Reliance e3 z \u2227 For e3 v)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z\"\\n  (* Hypothesis: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)\\n  shows \"\u2203x y z e1 e2 e3. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u27f6 (Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 On e3 HRR \u2227 On e3 NHEJ)\"\\nproof -\\n  (* From the known information, we have PARPInhibitors x, DSBs y, and SSBreakRepair z. *)\\n  from asm have \"PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z\" <ATP>\\n  \\n  (* Explanation 1 implies that inhibition of PARP results in DSB and prevention of SS break repair. *)\\n  (* We can infer that PARP inhibitors cause replication-associated DSBs by preventing SS break repair. *)\\n  have \"Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z\" <ATP>\\n  \\n  (* Explanation 2 and derived implications suggest reliance on defective HRR. *)\\n  (* Explanation 3 suggests reliance on error-prone NHEJ for DNA repair. *)\\n  have \"Rely e3 \u2227 Agent e3 x \u2227 On e3 HRR \u2227 On e3 NHEJ\" <ATP>\\n  \\n  (* Combining these, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Inhibition of PARP (from Explanatory Sentence 1)\\nB: Collapsed replication forks (from Explanatory Sentence 1)\\nC: DSB (double-strand breaks) (from Explanatory Sentence 1)\\nD: Prevention of SS (single-strand) break repair (from Explanatory Sentence 1)\\nE: Loss of BRCA2 (from Explanatory Sentence 2)\\nF: Cancer development (from Explanatory Sentence 2)\\nG: Genomic instability (from Explanatory Sentence 2)\\nH: Defective HRR (homologous recombination repair) (from Explanatory Sentence 2)\\nI: Trapping of PARP1 at sites of DSBs (from Explanatory Sentence 3)\\nJ: Increased NHEJ (non-homologous end joining) (from Explanatory Sentence 3)\\nK: Increased toxicity (from Explanatory Sentence 3)\\nL: Reliance on error-prone NHEJ for DNA repair (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, And(B, C, D))\\nImplies(Inhibition of PARP, B & C & D)\\n--------\\nImplies(E, And(F, G, H))\\nImplies(Loss of BRCA2, F & G & H)\\n--------\\nImplies(I, And(J, K, L))\\nImplies(Trapping of PARP1 at sites of DSBs, J & K & L)\\n--------\\n\\nDerived Implications:\\nImplies(Not(D), Not(A))\\nImplies(Not(Prevention of SS  break repair), Not(Inhibition of PARP))\\n--------\\nImplies(Not(G), Not(E))\\nImplies(Not(Genomic instability), Not(Loss of BRCA2))\\n--------\\nImplies(I, K)\\nImplies(Trapping of PARP1 at sites of DSBs, Increased toxicity)\\n--------\\nImplies(A, C)\\nImplies(Inhibition of PARP, DSB)\\n--------\\nImplies(Not(F), Not(E))\\nImplies(Not(Cancer development), Not(Loss of BRCA2))\\n--------\\nImplies(E, H)\\nImplies(Loss of BRCA2, Defective HRR)\\n--------\\nImplies(Not(K), Not(I))\\nImplies(Not(Increased toxicity), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(E, G)\\nImplies(Loss of BRCA2, Genomic instability)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(DSB), Not(Inhibition of PARP))\\n--------\\nImplies(I, J)\\nImplies(Trapping of PARP1 at sites of DSBs, Increased NHEJ)\\n--------\\nImplies(A, B)\\nImplies(Inhibition of PARP, Collapsed replication forks)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(Collapsed replication forks), Not(Inhibition of PARP))\\n--------\\nImplies(A, D)\\nImplies(Inhibition of PARP, Prevention of SS  break repair)\\n--------\\nImplies(Not(H), Not(E))\\nImplies(Not(Defective HRR), Not(Loss of BRCA2))\\n--------\\nImplies(Not(J), Not(I))\\nImplies(Not(Increased NHEJ), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(E, F)\\nImplies(Loss of BRCA2, Cancer development)\\n--------\\nImplies(Not(L), Not(I))\\nImplies(Not(Reliance on error-prone NHEJ for DNA repair), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(I, L)\\nImplies(Trapping of PARP1 at sites of DSBs, Reliance on error-prone NHEJ for DNA repair)\\n--------\\n'}",
            "5 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 provides that inhibition of PARP results in DSBs and prevents SS break repair. *)\\n(* We can use the derived implication Implies(A, C) to infer DSBs from inhibition of PARP. *)\\nhave \"DSBs y\" if \"InhibitionPARP x\" sledgehammer', 'solving time': 103.7424533367157, 'proof tactics': [], 'code': 'theory clinical_47_5\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  InhibitionPARP :: \"entity \u21d2 bool\"\\n  Forks :: \"entity \u21d2 bool\"\\n  DSB :: \"entity \u21d2 bool\"\\n  Collapsed :: \"entity \u21d2 bool\"\\n  Result :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  LossBRCA2 :: \"entity \u21d2 bool\"\\n  CancerDevelopment :: \"entity \u21d2 bool\"\\n  GenomicInstability :: \"entity \u21d2 bool\"\\n  Drive :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  DefectiveHRR :: \"entity \u21d2 bool\"\\n  Involve :: \"event \u21d2 bool\"\\n  TrappingPARP1 :: \"entity \u21d2 bool\"\\n  SitesDSBs :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  Toxicity :: \"entity \u21d2 bool\"\\n  Increase :: \"event \u21d2 bool\"\\n  Reliance :: \"event \u21d2 bool\"\\n  ErrorProneNHEJ :: \"entity \u21d2 bool\"\\n  RepairDNA :: \"entity \u21d2 bool\"\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Inhibition of PARP results in collapsed replication forks and DSB, and prevents SS break repair. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2. InhibitionPARP x \u2227 Forks y \u2227 DSB z \u2227 Collapsed y \u2227 Result e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Patient e1 z \u2227 SSBreakRepair z \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z\"\\n\\n(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective HRR. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. LossBRCA2 x \u2227 CancerDevelopment y \u2227 GenomicInstability z \u2227 Drive e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Via e1 z \u2227 DefectiveHRR z \u2227 Involve e2 \u2227 Agent e2 z \u2227 Patient e2 x\"\\n\\n(* Explanation 3: Trapping of PARP1 at sites of DSBs increases NHEJ and increases toxicity, indicating reliance on error-prone NHEJ for DNA repair. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2 e3. TrappingPARP1 x \u2227 SitesDSBs y \u2227 NHEJ z \u2227 Toxicity z \u2227 Increase e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Increase e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Reliance e3 \u2227 Agent e3 x \u2227 ErrorProneNHEJ z \u2227 RepairDNA z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitors x \u2227 SSBreakRepair z \u2227 DefectiveHRR z \u2227 ErrorProneNHEJ z \u2227 RepairDNA z\"\\n  (* Hypothesis: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA *)\\n  shows \"\u2203x y z e1 e2 e3. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 DefectiveHRR z \u2227 ErrorProneNHEJ z \u2227 RepairDNA z\"\\nproof -\\n  (* From the premise, we have known information about PARP inhibitors, SS break repair, defective HRR, error-prone NHEJ, and DNA repair. *)\\n  from asm have \"PARPInhibitors x \u2227 SSBreakRepair z \u2227 DefectiveHRR z \u2227 ErrorProneNHEJ z \u2227 RepairDNA z\" <ATP>\\n  \\n  (* Explanation 1 provides that inhibition of PARP results in DSBs and prevents SS break repair. *)\\n  (* We can use the derived implication Implies(A, C) to infer DSBs from inhibition of PARP. *)\\n  have \"DSBs y\" if \"InhibitionPARP x\" <ATP>\\n  \\n  (* Explanation 3 indicates reliance on error-prone NHEJ for DNA repair. *)\\n  (* We can use the logical relation Implies(I, L) to infer reliance on error-prone NHEJ. *)\\n  have \"Reliance e3 \u2227 Agent e3 x \u2227 ErrorProneNHEJ z \u2227 RepairDNA z\" if \"TrappingPARP1 x\" <ATP>\\n  \\n  (* Combine the information to show the hypothesis. *)\\n  then have \"\u2203x y z e1 e2 e3. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 DefectiveHRR z \u2227 ErrorProneNHEJ z \u2227 RepairDNA z\" <ATP>\\n  \\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Inhibition of PARP (from Explanatory Sentence 1)\\nB: Collapsed replication forks (from Explanatory Sentence 1)\\nC: DSB (double-strand breaks) (from Explanatory Sentence 1)\\nD: Prevention of SS (single-strand) break repair (from Explanatory Sentence 1)\\nE: Loss of BRCA2 (from Explanatory Sentence 2)\\nF: Cancer development (from Explanatory Sentence 2)\\nG: Genomic instability (from Explanatory Sentence 2)\\nH: Defective HRR (homologous recombination repair) (from Explanatory Sentence 2)\\nI: Trapping of PARP1 at sites of DSBs (from Explanatory Sentence 3)\\nJ: Increase in NHEJ (non-homologous end joining) (from Explanatory Sentence 3)\\nK: Increase in toxicity (from Explanatory Sentence 3)\\nL: Reliance on error-prone NHEJ for DNA repair (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, And(B, C, D))\\nImplies(Inhibition of PARP, B & C & D)\\n--------\\nImplies(E, And(F, G, H))\\nImplies(Loss of BRCA2, F & G & H)\\n--------\\nImplies(I, And(J, K, L))\\nImplies(Trapping of PARP1 at sites of DSBs, J & K & L)\\n--------\\n\\nDerived Implications:\\nImplies(Not(D), Not(A))\\nImplies(Not(Prevention of SS  break repair), Not(Inhibition of PARP))\\n--------\\nImplies(Not(G), Not(E))\\nImplies(Not(Genomic instability), Not(Loss of BRCA2))\\n--------\\nImplies(I, K)\\nImplies(Trapping of PARP1 at sites of DSBs, Increase in toxicity)\\n--------\\nImplies(A, C)\\nImplies(Inhibition of PARP, DSB)\\n--------\\nImplies(Not(F), Not(E))\\nImplies(Not(Cancer development), Not(Loss of BRCA2))\\n--------\\nImplies(E, H)\\nImplies(Loss of BRCA2, Defective HRR)\\n--------\\nImplies(Not(K), Not(I))\\nImplies(Not(Increase in toxicity), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(E, G)\\nImplies(Loss of BRCA2, Genomic instability)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(DSB), Not(Inhibition of PARP))\\n--------\\nImplies(I, J)\\nImplies(Trapping of PARP1 at sites of DSBs, Increase in NHEJ)\\n--------\\nImplies(A, B)\\nImplies(Inhibition of PARP, Collapsed replication forks)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(Collapsed replication forks), Not(Inhibition of PARP))\\n--------\\nImplies(A, D)\\nImplies(Inhibition of PARP, Prevention of SS  break repair)\\n--------\\nImplies(Not(H), Not(E))\\nImplies(Not(Defective HRR), Not(Loss of BRCA2))\\n--------\\nImplies(Not(J), Not(I))\\nImplies(Not(Increase in NHEJ), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(E, F)\\nImplies(Loss of BRCA2, Cancer development)\\n--------\\nImplies(Not(L), Not(I))\\nImplies(Not(Reliance on error-prone NHEJ for DNA repair), Not(Trapping of PARP1 at sites of DSBs))\\n--------\\nImplies(I, L)\\nImplies(Trapping of PARP1 at sites of DSBs, Reliance on error-prone NHEJ for DNA repair)\\n--------\\n'}",
            "6 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 provides that inhibition of PARP causes double-strand breaks and prevents single-strand break repair. *)\\n(* Logical relations Implies(A, B) and Implies(A, C) are relevant here. *)\\n(* Since PARP inhibitors are a form of inhibition of PARP, we can infer double-strand breaks and prevention of single-strand break repair. *)\\nthen have \"DSBs y \u2227 SSBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z\" sledgehammer', 'solving time': 103.1696629524231, 'proof tactics': [], 'code': 'theory clinical_47_6\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  InhibitionPARP :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  ReplicationForks :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  LeadTo :: \"event \u21d2 bool\"\\n  Collapsed :: \"entity \u21d2 bool\"\\n  LossBRCA2 :: \"entity \u21d2 bool\"\\n  CancerDevelopment :: \"entity \u21d2 bool\"\\n  GenomicInstability :: \"entity \u21d2 bool\"\\n  Drive :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Involve :: \"event \u21d2 bool\"\\n  HRRDefective :: \"event \u21d2 bool\"\\n  TrappingPARP1 :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  Toxicity :: \"entity \u21d2 bool\"\\n  Increase :: \"event \u21d2 bool\"\\n  Indicate :: \"event \u21d2 bool\"\\n  Reliance :: \"event \u21d2 bool\"\\n  NHEJErrorProne :: \"event \u21d2 bool\"\\n  RepairDNA :: \"event \u21d2 bool\"\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: Inhibition of PARP directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w e1 e2 e3. InhibitionPARP x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 ReplicationForks w \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 LeadTo e3 \u2227 Agent e3 x \u2227 Patient e3 w \u2227 Collapsed w\"\\n\\n(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. LossBRCA2 x \u2227 CancerDevelopment y \u2227 GenomicInstability z \u2227 Drive e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Via e1 z \u2227 Involve e2 \u2227 Agent e2 z \u2227 HRRDefective e2\"\\n\\n(* Explanation 3: Trapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z w e1 e2 e3. TrappingPARP1 x \u2227 DSBs y \u2227 NHEJ z \u2227 Toxicity w \u2227 Increase e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Increase e2 \u2227 Agent e2 x \u2227 Patient e2 w \u2227 Indicate e3 \u2227 Agent e3 x \u2227 Reliance e3 \u2227 NHEJErrorProne e3 \u2227 RepairDNA e3\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitors x\"\\n  (* Hypothesis: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA *)\\n  shows \"\u2203x y z e1 e2 e3. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 RelyOn e3 \u2227 Agent e3 x \u2227 HRRDefective e3 \u2227 NHEJErrorProne e3 \u2227 RepairDNA e3\"\\nproof -\\n  (* From the premise, we have the known information about PARP inhibitors. *)\\n  from asm have \"PARPInhibitors x\" <ATP>\\n  (* Explanation 1 provides that inhibition of PARP causes double-strand breaks and prevents single-strand break repair. *)\\n  (* Logical relations Implies(A, B) and Implies(A, C) are relevant here. *)\\n  (* Since PARP inhibitors are a form of inhibition of PARP, we can infer double-strand breaks and prevention of single-strand break repair. *)\\n  then have \"DSBs y \u2227 SSBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z\" <ATP>\\n  (* Explanation 2 involves defective homologous recombination repair due to genomic instability. *)\\n  (* Explanation 3 indicates reliance on error-prone non-homologous end joining for DNA repair. *)\\n  (* Logical relations Implies(G, H) and Implies(J, L) are relevant here. *)\\n  (* We can infer reliance on error-prone non-homologous end joining and defective homologous recombination repair. *)\\n  then have \"RelyOn e3 \u2227 Agent e3 x \u2227 HRRDefective e3 \u2227 NHEJErrorProne e3 \u2227 RepairDNA e3\" <ATP>\\n  (* Combining all the inferred information, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Inhibition of PARP (from Explanatory Sentence 1)\\nB: Double-strand breaks occur (from Explanatory Sentence 1)\\nC: Single-strand break repair is prevented (from Explanatory Sentence 1)\\nD: Collapsed replication forks occur (from Explanatory Sentence 1)\\nE: Loss of BRCA2 (from Explanatory Sentence 2)\\nF: Cancer development occurs (from Explanatory Sentence 2)\\nG: Genomic instability occurs (from Explanatory Sentence 2)\\nH: Defective homologous recombination repair (from Explanatory Sentence 2)\\nI: Trapping of PARP1 at sites of double-strand breaks (from Explanatory Sentence 3)\\nJ: Non-homologous end joining increases (from Explanatory Sentence 3)\\nK: Toxicity increases (from Explanatory Sentence 3)\\nL: Reliance on error-prone non-homologous end joining for DNA repair (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(Inhibition of PARP, Double-strand breaks occur)\\n--------\\nImplies(A, C)\\nImplies(Inhibition of PARP, Single-strand break repair is prevented)\\n--------\\nImplies(A, D)\\nImplies(Inhibition of PARP, Collapsed replication forks occur)\\n--------\\nImplies(E, G)\\nImplies(Loss of BRCA2, Genomic instability occurs)\\n--------\\nImplies(G, F)\\nImplies(Genomic instability occurs, Cancer development occurs)\\n--------\\nImplies(G, H)\\nImplies(Genomic instability occurs, Defective homologous recombination repair)\\n--------\\nImplies(I, J)\\nImplies(Trapping of PARP1 at sites of double-strand breaks, Non-homologous end joining increases)\\n--------\\nImplies(I, K)\\nImplies(Trapping of PARP1 at sites of double-strand breaks, Toxicity increases)\\n--------\\nImplies(J, L)\\nImplies(Non-homologous end joining increases, Reliance on error-prone non-homologous end joining for DNA repair)\\n--------\\n\\nDerived Implications:\\nImplies(E, H)\\nImplies(Loss of BRCA2, Defective homologous recombination repair)\\n--------\\nImplies(Not(F), Not(E))\\nImplies(Not(Cancer development occurs), Not(Loss of BRCA2))\\n--------\\nImplies(Not(H), Not(E))\\nImplies(Not(Defective homologous recombination repair), Not(Loss of BRCA2))\\n--------\\nImplies(E, F)\\nImplies(Loss of BRCA2, Cancer development occurs)\\n--------\\nImplies(Not(L), Not(I))\\nImplies(Not(Reliance on error-prone non-homologous end joining for DNA repair), Not(Trapping of PARP1 at sites of double-strand breaks))\\n--------\\nImplies(I, L)\\nImplies(Trapping of PARP1 at sites of double-strand breaks, Reliance on error-prone non-homologous end joining for DNA repair)\\n--------\\n'}",
            "7 iteration: {'syntactic validity': True, 'error code': '(* There is a logical relation Implies(A, B), Implies(PARP inhibitors function by inhibiting PARP, double-strand breaks occur) *)\\n(* A is from explanatory sentence 1, B is from explanatory sentence 1. *)\\n(* We can infer double-strand breaks occur. *)\\nthen have \"DSBs y\" sledgehammer', 'solving time': 103.43712568283081, 'proof tactics': [], 'code': 'theory clinical_47_7\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  PARP :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  Function :: \"event \u21d2 bool\"\\n  Inhibit :: \"event \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  LeadTo :: \"event \u21d2 entity \u21d2 bool\"\\n  CollapsedReplicationForks :: \"entity \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  LossBRCA2 :: \"entity \u21d2 bool\"\\n  CancerDevelopment :: \"entity \u21d2 bool\"\\n  GenomicInstability :: \"entity \u21d2 bool\"\\n  Drive :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Involve :: \"event \u21d2 bool\"\\n  HRRDefective :: \"event \u21d2 bool\"\\n  TrappingPARP1 :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  Increase :: \"event \u21d2 bool\"\\n  Toxicity :: \"event \u21d2 bool\"\\n  Indicate :: \"event \u21d2 bool\"\\n  RelyOn :: \"event \u21d2 entity \u21d2 bool\"\\n  NHEJErrorProne :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors function by inhibiting PARP, which directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w e1 e2 e3 e4. PARPInhibitors x \u2227 PARP y \u2227 DSBs z \u2227 SSBreakRepair w \u2227 Function e1 \u2227 Agent e1 x \u2227 Inhibit e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Cause e3 \u2227 Agent e3 y \u2227 Patient e3 z \u2227 Prevent e4 \u2227 Agent e4 y \u2227 Patient e4 w \u2227 LeadTo e4 z \u2227 CollapsedReplicationForks z\"\\n\\n(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. LossBRCA2 x \u2227 CancerDevelopment y \u2227 GenomicInstability z \u2227 Drive e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Via e1 z \u2227 Involve e2 \u2227 Agent e2 z \u2227 HRRDefective e2\"\\n\\n(* Explanation 3: Trapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2 e3. TrappingPARP1 x \u2227 DSBs y \u2227 NHEJ z \u2227 Increase e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Increase e2 \u2227 Agent e2 x \u2227 Toxicity e2 \u2227 Indicate e3 \u2227 Agent e3 x \u2227 RelyOn e3 z \u2227 NHEJErrorProne z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitors x\"\\n  (* Hypothesis: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)\\n  shows \"\u2203x y z e1 e2 e3. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 RelyOn e3 z \u2227 HRRDefective e3 \u2227 NHEJErrorProne z\"\\nproof -\\n  (* From the premise, we have the known information about PARP inhibitors. *)\\n  from asm have \"PARPInhibitors x\" <ATP>\\n  (* There is a logical relation Implies(A, B), Implies(PARP inhibitors function by inhibiting PARP, double-strand breaks occur) *)\\n  (* A is from explanatory sentence 1, B is from explanatory sentence 1. *)\\n  (* We can infer double-strand breaks occur. *)\\n  then have \"DSBs y\" <ATP>\\n  (* There is a logical relation Implies(A, C), Implies(PARP inhibitors function by inhibiting PARP, single-strand break repair is prevented) *)\\n  (* We can infer single-strand break repair is prevented. *)\\n  then have \"SSBreakRepair z\" <ATP>\\n  (* There is a logical relation Implies(G, H), Implies(genomic instability occurs, defective homologous recombination repair occurs) *)\\n  (* From explanation 2, we know that genomic instability involves defective homologous recombination repair. *)\\n  then have \"HRRDefective e3\" <ATP>\\n  (* There is a logical relation Implies(I, L), Implies(trapping of PARP1 at sites of double-strand breaks, reliance on error-prone non-homologous end joining for DNA repair) *)\\n  (* From explanation 3, we know that trapping of PARP1 indicates reliance on error-prone non-homologous end joining. *)\\n  then have \"NHEJErrorProne z\" <ATP>\\n  (* Combine all the inferred information to prove the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors function by inhibiting PARP (from Explanatory Sentence 1)\\nB: double-strand breaks occur (from Explanatory Sentence 1)\\nC: single-strand break repair is prevented (from Explanatory Sentence 1)\\nD: replication forks collapse (from Explanatory Sentence 1)\\nE: loss of BRCA2 (from Explanatory Sentence 2)\\nF: cancer development occurs (from Explanatory Sentence 2)\\nG: genomic instability occurs (from Explanatory Sentence 2)\\nH: defective homologous recombination repair occurs (from Explanatory Sentence 2)\\nI: trapping of PARP1 at sites of double-strand breaks (from Explanatory Sentence 3)\\nJ: non-homologous end joining increases (from Explanatory Sentence 3)\\nK: toxicity increases (from Explanatory Sentence 3)\\nL: reliance on error-prone non-homologous end joining for DNA repair (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(PARP inhibitors function by inhibiting PARP, double-strand breaks occur)\\n--------\\nImplies(A, C)\\nImplies(PARP inhibitors function by inhibiting PARP, single-strand break repair is prevented)\\n--------\\nImplies(A, D)\\nImplies(PARP inhibitors function by inhibiting PARP, replication forks collapse)\\n--------\\nImplies(E, G)\\nImplies(loss of BRCA2, genomic instability occurs)\\n--------\\nImplies(G, H)\\nImplies(genomic instability occurs, defective homologous recombination repair occurs)\\n--------\\nImplies(E, F)\\nImplies(loss of BRCA2, cancer development occurs)\\n--------\\nImplies(I, J)\\nImplies(trapping of PARP1 at sites of double-strand breaks, non-homologous end joining increases)\\n--------\\nImplies(I, K)\\nImplies(trapping of PARP1 at sites of double-strand breaks, toxicity increases)\\n--------\\nImplies(K, L)\\nImplies(toxicity increases, reliance on error-prone non-homologous end joining for DNA repair)\\n--------\\n\\nDerived Implications:\\nImplies(Not(H), Not(E))\\nImplies(Not(defective homologous recombination repair occurs), Not(loss of BRCA2))\\n--------\\nImplies(E, H)\\nImplies(loss of BRCA2, defective homologous recombination repair occurs)\\n--------\\nImplies(Not(L), Not(I))\\nImplies(Not(reliance on error-prone non-homologous end joining for DNA repair), Not(trapping of PARP1 at sites of double-strand breaks))\\n--------\\nImplies(I, L)\\nImplies(trapping of PARP1 at sites of double-strand breaks, reliance on error-prone non-homologous end joining for DNA repair)\\n--------\\n'}",
            "8 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 provides that PARP inhibitors cause double-strand breaks and prevent single-strand break repair. *)\\n(* Logical relations Implies(A, B) and Implies(A, C) support this. *)\\nthen obtain y z e1 e2 where \"DSBs y \u2227 SSBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z\" sledgehammer', 'solving time': 103.48729658126831, 'proof tactics': [], 'code': 'theory clinical_47_8\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  PARP :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  CollapsedReplicationForks :: \"event \u21d2 bool\"\\n  Function :: \"event \u21d2 bool\"\\n  Inhibit :: \"event \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  LeadTo :: \"event \u21d2 bool\"\\n  LossBRCA2 :: \"entity \u21d2 bool\"\\n  CancerDevelopment :: \"entity \u21d2 bool\"\\n  GenomicInstability :: \"entity \u21d2 bool\"\\n  Drive :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Involve :: \"event \u21d2 bool\"\\n  DefectiveHRR :: \"event \u21d2 bool\"\\n  TrappingPARP1 :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  Toxicity :: \"entity \u21d2 bool\"\\n  Increase :: \"event \u21d2 bool\"\\n  Indicate :: \"event \u21d2 bool\"\\n  Reliance :: \"event \u21d2 bool\"\\n  ErrorProneNHEJ :: \"event \u21d2 bool\"\\n  InhibitionPARP :: \"entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  Occurrence :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors function by inhibiting PARP, which directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w e1 e2 e3 e4 e5. PARPInhibitors x \u2227 PARP y \u2227 DSBs z \u2227 SSBreakRepair w \u2227 CollapsedReplicationForks e5 \u2227 Function e1 \u2227 Agent e1 x \u2227 Inhibit e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Cause e3 \u2227 Agent e3 x \u2227 Patient e3 z \u2227 Prevent e4 \u2227 Agent e4 x \u2227 Patient e4 w \u2227 LeadTo e5 \u2227 Agent e5 x\"\\n\\n(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. LossBRCA2 x \u2227 CancerDevelopment y \u2227 GenomicInstability z \u2227 Drive e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Via e1 z \u2227 Involve e2 \u2227 Agent e2 z \u2227 DefectiveHRR e2\"\\n\\n(* Explanation 3: Trapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z w e1 e2 e3. TrappingPARP1 x \u2227 DSBs y \u2227 NHEJ z \u2227 Toxicity w \u2227 Increase e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Increase e2 \u2227 Agent e2 x \u2227 Patient e2 w \u2227 Indicate e3 \u2227 Agent e3 x \u2227 Reliance e3 \u2227 ErrorProneNHEJ e3\"\\n\\n(* Explanation 4: The inhibition of PARP by PARP inhibitors directly leads to the occurrence of double-strand breaks. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z e1 e2. InhibitionPARP x \u2227 PARPInhibitors y \u2227 DSBs z \u2227 Lead e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Occurrence e2 \u2227 Agent e2 z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitors x\"\\n  (* Hypothesis: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA *)\\n  shows \"\u2203x y z e1 e2 e3. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 DefectiveHRR e3 \u2227 ErrorProneNHEJ e3\"\\nproof -\\n  (* From the premise, we have the known information about PARP inhibitors. *)\\n  from asm have \"PARPInhibitors x\" <ATP>\\n  (* Explanation 1 provides that PARP inhibitors cause double-strand breaks and prevent single-strand break repair. *)\\n  (* Logical relations Implies(A, B) and Implies(A, C) support this. *)\\n  then obtain y z e1 e2 where \"DSBs y \u2227 SSBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z\" <ATP>\\n  (* Explanation 2 and its logical relations show that genomic instability involves defective homologous recombination repair. *)\\n  (* Explanation 3 and its logical relations show reliance on error-prone non-homologous end joining for DNA repair. *)\\n  then obtain e3 where \"Rely e3 \u2227 Agent e3 x \u2227 DefectiveHRR e3 \u2227 ErrorProneNHEJ e3\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors function by inhibiting PARP (from Explanatory Sentence 1)\\nB: double-strand breaks occur (from Explanatory Sentence 1 and 4)\\nC: single-strand break repair is prevented (from Explanatory Sentence 1)\\nD: replication forks collapse (from Explanatory Sentence 1)\\nE: loss of BRCA2 (from Explanatory Sentence 2)\\nF: cancer development occurs (from Explanatory Sentence 2)\\nG: genomic instability occurs (from Explanatory Sentence 2)\\nH: defective homologous recombination repair occurs (from Explanatory Sentence 2)\\nI: PARP1 is trapped at sites of double-strand breaks (from Explanatory Sentence 3)\\nJ: non-homologous end joining increases (from Explanatory Sentence 3)\\nK: toxicity increases (from Explanatory Sentence 3)\\nL: reliance on error-prone non-homologous end joining for DNA repair (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(PARP inhibitors function by inhibiting PARP, double-strand breaks occur)\\n--------\\nImplies(A, C)\\nImplies(PARP inhibitors function by inhibiting PARP, single-strand break repair is prevented)\\n--------\\nImplies(A, D)\\nImplies(PARP inhibitors function by inhibiting PARP, replication forks collapse)\\n--------\\nImplies(E, G)\\nImplies(loss of BRCA2, genomic instability occurs)\\n--------\\nImplies(G, H)\\nImplies(genomic instability occurs, defective homologous recombination repair occurs)\\n--------\\nImplies(E, F)\\nImplies(loss of BRCA2, cancer development occurs)\\n--------\\nImplies(I, J)\\nImplies(PARP1 is trapped at sites of double-strand breaks, non-homologous end joining increases)\\n--------\\nImplies(J, K)\\nImplies(non-homologous end joining increases, toxicity increases)\\n--------\\nImplies(J, L)\\nImplies(non-homologous end joining increases, reliance on error-prone non-homologous end joining for DNA repair)\\n--------\\nImplies(A, B)\\nImplies(PARP inhibitors function by inhibiting PARP, double-strand breaks occur)\\n--------\\n\\nDerived Implications:\\nImplies(I, K)\\nImplies(PARP1 is trapped at sites of double-strand breaks, toxicity increases)\\n--------\\nImplies(E, H)\\nImplies(loss of BRCA2, defective homologous recombination repair occurs)\\n--------\\nImplies(Not(K), Not(I))\\nImplies(Not(toxicity increases), Not(PARP1 is trapped at sites of double-strand breaks))\\n--------\\nImplies(Not(H), Not(E))\\nImplies(Not(defective homologous recombination repair occurs), Not(loss of BRCA2))\\n--------\\nImplies(Not(L), Not(I))\\nImplies(Not(reliance on error-prone non-homologous end joining for DNA repair), Not(PARP1 is trapped at sites of double-strand breaks))\\n--------\\nImplies(I, L)\\nImplies(PARP1 is trapped at sites of double-strand breaks, reliance on error-prone non-homologous end joining for DNA repair)\\n--------\\n'}",
            "9 iteration: {'syntactic validity': True, 'error code': '(* There is a logical relation Implies(A, B), Implies(PARP inhibitors inhibit PARP, double-strand breaks occur) *)\\n(* From explanation 1, we know that PARP inhibitors inhibit PARP, which causes double-strand breaks. *)\\nthen have \"DSBs y\" sledgehammer', 'solving time': 103.62837505340576, 'proof tactics': [], 'code': 'theory clinical_47_9\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  PARP :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  Function :: \"event \u21d2 bool\"\\n  Inhibit :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  LeadTo :: \"event \u21d2 bool\"\\n  CollapsedReplicationForks :: \"event \u21d2 bool\"\\n  RelianceOnErrorProneNHEJ :: \"event \u21d2 bool\"\\n  LossOfBRCA2 :: \"entity \u21d2 bool\"\\n  CancerDevelopment :: \"entity \u21d2 bool\"\\n  GenomicInstability :: \"entity \u21d2 bool\"\\n  Drive :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Involve :: \"event \u21d2 bool\"\\n  DefectiveHRR :: \"event \u21d2 bool\"\\n  TrappingOfPARP1 :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  Increase :: \"event \u21d2 bool\"\\n  Toxicity :: \"event \u21d2 bool\"\\n  Indicate :: \"event \u21d2 bool\"\\n  InhibitionOfPARP :: \"entity \u21d2 bool\"\\n  Contribute :: \"event \u21d2 bool\"\\n  ErrorProneNHEJ :: \"event \u21d2 bool\"\\n  RelyOn :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors function by inhibiting PARP, which directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks and reliance on error-prone non-homologous end joining for DNA repair *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w e1 e2 e3 e4 e5. PARPInhibitors x \u2227 PARP y \u2227 DSBs z \u2227 SSBreakRepair w \u2227 Function e1 \u2227 Agent e1 x \u2227 Inhibit e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Cause e3 \u2227 Agent e3 y \u2227 Patient e3 z \u2227 Prevent e4 \u2227 Agent e4 y \u2227 Patient e4 w \u2227 LeadTo e5 \u2227 CollapsedReplicationForks e5 \u2227 RelianceOnErrorProneNHEJ e5\"\\n\\n(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. LossOfBRCA2 x \u2227 CancerDevelopment y \u2227 GenomicInstability z \u2227 Drive e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Via e1 z \u2227 Involve e2 \u2227 Agent e2 z \u2227 DefectiveHRR e2\"\\n\\n(* Explanation 3: Trapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2 e3. TrappingOfPARP1 x \u2227 DSBs y \u2227 NHEJ z \u2227 Increase e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Toxicity e2 \u2227 Increase e2 \u2227 Agent e2 x \u2227 Indicate e3 \u2227 RelianceOnErrorProneNHEJ e3\"\\n\\n(* Explanation 4: The inhibition of PARP by PARP inhibitors directly leads to the occurrence of double-strand breaks and prevents single-strand break repair, which contributes to defective homologous recombination repair *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w e1 e2 e3. InhibitionOfPARP x \u2227 PARPInhibitors y \u2227 DSBs z \u2227 SSBreakRepair w \u2227 LeadTo e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 w \u2227 Contribute e3 \u2227 DefectiveHRR e3\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitors x\"\\n  (* Hypothesis: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA *)\\n  shows \"\u2203x y z e1 e2 e3. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 RelyOn e3 \u2227 Agent e3 x \u2227 DefectiveHRR e3 \u2227 ErrorProneNHEJ e3\"\\nproof -\\n  (* From the premise, we have the known information about PARP inhibitors. *)\\n  from asm have \"PARPInhibitors x\" <ATP>\\n  (* There is a logical relation Implies(A, B), Implies(PARP inhibitors inhibit PARP, double-strand breaks occur) *)\\n  (* From explanation 1, we know that PARP inhibitors inhibit PARP, which causes double-strand breaks. *)\\n  then have \"DSBs y\" <ATP>\\n  (* There is a logical relation Implies(A, C), Implies(PARP inhibitors inhibit PARP, single-strand break repair is prevented) *)\\n  (* From explanation 1, we know that PARP inhibitors inhibit PARP, which prevents single-strand break repair. *)\\n  then have \"SSBreakRepair z\" <ATP>\\n  (* There is a logical relation Implies(A, I), Implies(PARP inhibitors inhibit PARP, defective homologous recombination repair) *)\\n  (* From explanation 4, we know that inhibition of PARP by PARP inhibitors contributes to defective homologous recombination repair. *)\\n  then have \"DefectiveHRR e3\" <ATP>\\n  (* There is a logical relation Implies(A, E), Implies(PARP inhibitors inhibit PARP, reliance on error-prone non-homologous end joining for DNA repair) *)\\n  (* From explanation 1, we know that PARP inhibitors lead to reliance on error-prone non-homologous end joining for DNA repair. *)\\n  then have \"ErrorProneNHEJ e3\" <ATP>\\n  (* Combine all the derived information to show the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors inhibit PARP (from Explanatory Sentence 1)\\nB: double-strand breaks occur (from Explanatory Sentence 1)\\nC: single-strand break repair is prevented (from Explanatory Sentence 1)\\nD: collapsed replication forks occur (from Explanatory Sentence 1)\\nE: reliance on error-prone non-homologous end joining for DNA repair (from Explanatory Sentence 1)\\nF: loss of BRCA2 (from Explanatory Sentence 2)\\nG: cancer development occurs (from Explanatory Sentence 2)\\nH: genomic instability occurs (from Explanatory Sentence 2)\\nI: defective homologous recombination repair (from Explanatory Sentence 2 and 4)\\nJ: trapping of PARP1 at sites of double-strand breaks (from Explanatory Sentence 3)\\nK: increased non-homologous end joining (from Explanatory Sentence 3)\\nL: increased toxicity (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(PARP inhibitors inhibit PARP, double-strand breaks occur)\\n--------\\nImplies(A, C)\\nImplies(PARP inhibitors inhibit PARP, single-strand break repair is prevented)\\n--------\\nImplies(B, D)\\nImplies(double-strand breaks occur, collapsed replication forks occur)\\n--------\\nImplies(D, E)\\nImplies(collapsed replication forks occur, reliance on error-prone non-homologous end joining for DNA repair)\\n--------\\nImplies(F, H)\\nImplies(loss of BRCA2, genomic instability occurs)\\n--------\\nImplies(H, G)\\nImplies(genomic instability occurs, cancer development occurs)\\n--------\\nImplies(H, I)\\nImplies(genomic instability occurs, defective homologous recombination repair)\\n--------\\nImplies(J, K)\\nImplies(trapping of PARP1 at sites of double-strand breaks, increased non-homologous end joining)\\n--------\\nImplies(K, L)\\nImplies(increased non-homologous end joining, increased toxicity)\\n--------\\nImplies(A, I)\\nImplies(PARP inhibitors inhibit PARP, defective homologous recombination repair)\\n--------\\n\\nDerived Implications:\\nImplies(Not(G), Not(F))\\nImplies(Not(cancer development occurs), Not(loss of BRCA2))\\n--------\\nImplies(Not(E), Not(A))\\nImplies(Not(reliance on error-prone non-homologous end joining for DNA repair), Not(PARP inhibitors inhibit PARP))\\n--------\\nImplies(Not(D), Not(A))\\nImplies(Not(collapsed replication forks occur), Not(PARP inhibitors inhibit PARP))\\n--------\\nImplies(F, I)\\nImplies(loss of BRCA2, defective homologous recombination repair)\\n--------\\nImplies(Not(E), Not(B))\\nImplies(Not(reliance on error-prone non-homologous end joining for DNA repair), Not(double-strand breaks occur))\\n--------\\nImplies(B, E)\\nImplies(double-strand breaks occur, reliance on error-prone non-homologous end joining for DNA repair)\\n--------\\nImplies(Not(I), Not(F))\\nImplies(Not(defective homologous recombination repair), Not(loss of BRCA2))\\n--------\\nImplies(F, G)\\nImplies(loss of BRCA2, cancer development occurs)\\n--------\\nImplies(J, L)\\nImplies(trapping of PARP1 at sites of double-strand breaks, increased toxicity)\\n--------\\nImplies(A, D)\\nImplies(PARP inhibitors inhibit PARP, collapsed replication forks occur)\\n--------\\nImplies(Not(L), Not(J))\\nImplies(Not(increased toxicity), Not(trapping of PARP1 at sites of double-strand breaks))\\n--------\\nImplies(A, E)\\nImplies(PARP inhibitors inhibit PARP, reliance on error-prone non-homologous end joining for DNA repair)\\n--------\\n'}",
            "10 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 6.6760218143463135, 'proof tactics': ['Type unification failed: Clash of types \"_ \\\\<Rightarrow> _\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  On e3 :: entity \\\\<Rightarrow> bool\\nOperand:   HRR :: entity \\\\<Rightarrow> bool\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_47_10\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  PARPInhibitors :: \"entity \u21d2 bool\"\\n  PARP :: \"entity \u21d2 bool\"\\n  DSBs :: \"entity \u21d2 bool\"\\n  SSBreakRepair :: \"entity \u21d2 bool\"\\n  Function :: \"event \u21d2 bool\"\\n  Inhibit :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  Prevent :: \"event \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  To :: \"event \u21d2 entity \u21d2 bool\"\\n  CollapsedReplicationForks :: \"entity \u21d2 bool\"\\n  RelianceOnNHEJ :: \"entity \u21d2 bool\"\\n  LossOfBRCA2 :: \"entity \u21d2 bool\"\\n  CancerDevelopment :: \"entity \u21d2 bool\"\\n  GenomicInstability :: \"entity \u21d2 bool\"\\n  Drive :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Involve :: \"event \u21d2 bool\"\\n  HRR :: \"entity \u21d2 bool\"\\n  TrappingOfPARP1 :: \"entity \u21d2 bool\"\\n  NHEJ :: \"entity \u21d2 bool\"\\n  Increase :: \"event \u21d2 bool\"\\n  Toxicity :: \"entity \u21d2 bool\"\\n  Indicate :: \"event \u21d2 bool\"\\n  RelianceOn :: \"event \u21d2 entity \u21d2 bool\"\\n  InhibitionOfPARP :: \"entity \u21d2 bool\"\\n  Contribute :: \"event \u21d2 bool\"\\n  Rely :: \"event \u21d2 bool\"\\n  On :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: PARP inhibitors function by inhibiting PARP, which directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks and reliance on error-prone non-homologous end joining for DNA repair. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v1 v2 e1 e2 e3 e4 e5. PARPInhibitors x \u2227 PARP y \u2227 DSBs z \u2227 SSBreakRepair w \u2227 Function e1 \u2227 Agent e1 x \u2227 Inhibit e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 Cause e3 \u2227 Agent e3 x \u2227 Patient e3 z \u2227 Prevent e4 \u2227 Agent e4 x \u2227 Patient e4 w \u2227 Lead e5 \u2227 Agent e5 x \u2227 To e5 v1 \u2227 CollapsedReplicationForks v1 \u2227 To e5 v2 \u2227 RelianceOnNHEJ v2\"\\n\\n(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z v e1 e2. LossOfBRCA2 x \u2227 CancerDevelopment y \u2227 GenomicInstability z \u2227 Drive e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Via e1 z \u2227 Involve e2 \u2227 Agent e2 z \u2227 Patient e2 v \u2227 HRR v\"\\n\\n(* Explanation 3: Trapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z v e1 e2 e3. TrappingOfPARP1 x \u2227 DSBs y \u2227 NHEJ z \u2227 Increase e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Increase e2 \u2227 Agent e2 x \u2227 Patient e2 v \u2227 Toxicity v \u2227 Indicate e3 \u2227 Agent e3 x \u2227 RelianceOn e3 v \u2227 NHEJ v\"\\n\\n(* Explanation 4: The inhibition of PARP by PARP inhibitors directly leads to the occurrence of double-strand breaks and prevents single-strand break repair, which contributes to defective homologous recombination repair. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z w v e1 e2 e3. InhibitionOfPARP x \u2227 PARPInhibitors y \u2227 DSBs z \u2227 SSBreakRepair w \u2227 Lead e1 \u2227 Agent e1 x \u2227 To e1 z \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 w \u2227 Contribute e3 \u2227 Agent e3 x \u2227 Patient e3 v \u2227 HRR v\"\\n\\n(* Explanation 5: The inhibition of PARP by PARP inhibitors directly causes double-strand breaks, which leads to reliance on error-prone non-homologous end joining for DNA repair. *)\\naxiomatization where\\n  explanation_5: \"\u2203x y z v e1 e2. InhibitionOfPARP x \u2227 PARPInhibitors y \u2227 DSBs z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Lead e2 \u2227 Agent e2 x \u2227 RelianceOn e2 v \u2227 NHEJ v\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PARPInhibitors x\"\\n  (* Hypothesis: PARP inhibitors cause replication\u2010associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)\\n  shows \"\u2203x y z e1 e2 e3. PARPInhibitors x \u2227 DSBs y \u2227 SSBreakRepair z \u2227 Cause e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Prevent e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Rely e3 \u2227 Agent e3 x \u2227 On e3 HRR \u2227 On e3 NHEJ\"\\nproof -\\n  (* From the premise, we have the known information about PARP inhibitors. *)\\n  from asm have \"PARPInhibitors x\" <ATP>\\n  (* Explanation 1 provides the logical relations Implies(A, B) and Implies(A, C). *)\\n  (* From Implies(A, B), we can infer that double-strand breaks occur. *)\\n  then have \"DSBs y\" <ATP>\\n  (* From Implies(A, C), we can infer that single-strand break repair is prevented. *)\\n  then have \"SSBreakRepair z\" <ATP>\\n  (* Explanation 5 provides the logical relation Implies(A, E). *)\\n  (* From Implies(A, E), we can infer reliance on error-prone non-homologous end joining for DNA repair. *)\\n  then have \"Rely e3 \u2227 Agent e3 x \u2227 On e3 NHEJ\" <ATP>\\n  (* Explanation 4 provides the logical relation Implies(A, I). *)\\n  (* From Implies(A, I), we can infer defective homologous recombination repair. *)\\n  then have \"Rely e3 \u2227 Agent e3 x \u2227 On e3 HRR\" <ATP>\\n  (* Combine all the inferred information to satisfy the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: PARP inhibitors inhibit PARP (from Explanatory Sentence 1)\\nB: double-strand breaks occur (from Explanatory Sentence 1)\\nC: single-strand break repair is prevented (from Explanatory Sentence 1)\\nD: collapsed replication forks occur (from Explanatory Sentence 1)\\nE: reliance on error-prone non-homologous end joining for DNA repair (from Explanatory Sentence 1)\\nF: loss of BRCA2 (from Explanatory Sentence 2)\\nG: cancer development occurs (from Explanatory Sentence 2)\\nH: genomic instability occurs (from Explanatory Sentence 2)\\nI: defective homologous recombination repair (from Explanatory Sentence 2)\\nJ: trapping of PARP1 at sites of double-strand breaks (from Explanatory Sentence 3)\\nK: increased non-homologous end joining (from Explanatory Sentence 3)\\nL: increased toxicity (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(PARP inhibitors inhibit PARP, double-strand breaks occur)\\n--------\\nImplies(A, C)\\nImplies(PARP inhibitors inhibit PARP, single-strand break repair is prevented)\\n--------\\nImplies(B, D)\\nImplies(double-strand breaks occur, collapsed replication forks occur)\\n--------\\nImplies(D, E)\\nImplies(collapsed replication forks occur, reliance on error-prone non-homologous end joining for DNA repair)\\n--------\\nImplies(F, H)\\nImplies(loss of BRCA2, genomic instability occurs)\\n--------\\nImplies(H, I)\\nImplies(genomic instability occurs, defective homologous recombination repair)\\n--------\\nImplies(F, G)\\nImplies(loss of BRCA2, cancer development occurs)\\n--------\\nImplies(J, K)\\nImplies(trapping of PARP1 at sites of double-strand breaks, increased non-homologous end joining)\\n--------\\nImplies(K, L)\\nImplies(increased non-homologous end joining, increased toxicity)\\n--------\\nImplies(A, I)\\nImplies(PARP inhibitors inhibit PARP, defective homologous recombination repair)\\n--------\\nImplies(B, E)\\nImplies(double-strand breaks occur, reliance on error-prone non-homologous end joining for DNA repair)\\n--------\\n\\nDerived Implications:\\nImplies(Not(E), Not(A))\\nImplies(Not(reliance on error-prone non-homologous end joining for DNA repair), Not(PARP inhibitors inhibit PARP))\\n--------\\nImplies(Not(D), Not(A))\\nImplies(Not(collapsed replication forks occur), Not(PARP inhibitors inhibit PARP))\\n--------\\nImplies(F, I)\\nImplies(loss of BRCA2, defective homologous recombination repair)\\n--------\\nImplies(Not(I), Not(F))\\nImplies(Not(defective homologous recombination repair), Not(loss of BRCA2))\\n--------\\nImplies(J, L)\\nImplies(trapping of PARP1 at sites of double-strand breaks, increased toxicity)\\n--------\\nImplies(A, D)\\nImplies(PARP inhibitors inhibit PARP, collapsed replication forks occur)\\n--------\\nImplies(Not(L), Not(J))\\nImplies(Not(increased toxicity), Not(trapping of PARP1 at sites of double-strand breaks))\\n--------\\nImplies(A, E)\\nImplies(PARP inhibitors inhibit PARP, reliance on error-prone non-homologous end joining for DNA repair)\\n--------\\n'}"
        ]
    }
}